Keun Ho Park

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial

Joo Myung Lee, Hyun Kuk Kim, Keun Ho Park et al. · European Heart Journal · 2022 · 147 citations

Value of Early Risk Stratification Using Hemoglobin Level and Neutrophil-to-Lymphocyte Ratio in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Kyung Hoon Cho, Myung Ho Jeong, Daisuke Hachinohe et al. · The American Journal of Cardiology · 2011 · 102 citations

Percutaneous Coronary Intervention, Thrombosis, Cardiovascular Epidemiology +12

Plaque Characteristics in Culprit Lesions and Inflammatory Status in Diabetic Acute Coronary Syndrome Patients

Young Joon Hong, Myung Ho Jeong, Yun Ha Choi et al. · JACC. Cardiovascular imaging · 2009 · 83 citations

Inflammation, Inflammatory Status, Vascular Disease +13